Unrealized gain (loss) on investment in equity securities
ANI Pharmaceuticals·Business Segments·2 segments·Rolls up to Unrealized Gain (Loss) on Equity Securities
Breakdown
Segments
Generics and OtherView metric
Rare Disease and BrandsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Generics and Other | $0 | $0 | $0 | $0 | $0 |
| Rare Disease and Brands | $0 | $0 | $0 | $0 | $0 |
| Total | — | — | — | — | — |